As of 2025-12-31, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (82.11) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.43 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -410.7%.
The range of the Relative Valuation is (73.05) - (80.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 23.8x | 21.6x |
| Forward P/E multiples | 21.6x - 32.5x | 27.0x |
| Fair Price | (73.05) - (80.42) | (82.11) |
| Upside | -376.4% - -404.3% | -410.7% |
| Date | P/E |
| 2025-12-29 | -7.70 |
| 2025-12-26 | -7.81 |
| 2025-12-24 | -7.94 |
| 2025-12-23 | -7.87 |
| 2025-12-22 | -8.07 |
| 2025-12-19 | -7.58 |
| 2025-12-18 | -7.48 |
| 2025-12-17 | -7.63 |
| 2025-12-16 | -7.90 |
| 2025-12-15 | -8.02 |
| 2025-12-12 | -8.14 |
| 2025-12-11 | -8.27 |
| 2025-12-10 | -8.34 |
| 2025-12-09 | -8.31 |
| 2025-12-08 | -8.82 |
| 2025-12-05 | -8.72 |
| 2025-12-04 | -8.76 |
| 2025-12-03 | -8.23 |
| 2025-12-02 | -7.89 |
| 2025-12-01 | -7.67 |
| 2025-11-28 | -8.00 |
| 2025-11-26 | -7.93 |
| 2025-11-25 | -7.82 |
| 2025-11-24 | -7.79 |
| 2025-11-21 | -7.67 |
| 2025-11-20 | -7.42 |
| 2025-11-19 | -7.38 |
| 2025-11-18 | -7.57 |
| 2025-11-17 | -7.69 |
| 2025-11-14 | -7.56 |
| 2025-11-13 | -7.02 |
| 2025-11-12 | -7.18 |
| 2025-11-11 | -7.21 |
| 2025-11-10 | -6.71 |
| 2025-11-07 | -6.78 |
| 2025-11-06 | -6.88 |
| 2025-11-05 | -7.02 |
| 2025-11-04 | -7.06 |
| 2025-11-03 | -7.32 |
| 2025-10-31 | -7.91 |
| 2025-10-30 | -7.69 |
| 2025-10-29 | -7.69 |
| 2025-10-28 | -8.01 |
| 2025-10-27 | -8.10 |
| 2025-10-24 | -7.91 |
| 2025-10-23 | -7.77 |
| 2025-10-22 | -7.91 |
| 2025-10-21 | -8.26 |
| 2025-10-20 | -8.19 |
| 2025-10-17 | -7.94 |